These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33503871)

  • 1. Design and Synthesis of Novel Imidazole Derivatives Possessing Triazole Pharmacophore with Potent Anticancer Activity, and In Silico ADMET with GSK-3β Molecular Docking Investigations.
    Al-Blewi F; Shaikh SA; Naqvi A; Aljohani F; Aouad MR; Ihmaid S; Rezki N
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, anticancer activity and molecular modeling study of novel substituted triazole linked tetrafluoronaphthalene hybrid derivatives.
    Erdoğan M; Comert Onder F
    J Biomol Struct Dyn; 2024 Nov; 42(18):9767-9786. PubMed ID: 37676264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and
    Eldehna WM; Al-Rashood ST; Al-Warhi T; Eskandrani RO; Alharbi A; El Kerdawy AM
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):270-285. PubMed ID: 33327806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies.
    Turky A; Bayoumi AH; Sherbiny FF; El-Adl K; Abulkhair HS
    Mol Divers; 2021 Feb; 25(1):403-420. PubMed ID: 32830299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
    Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA
    Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Click synthesis of 1,2,3-triazole based imidazoles: Antitubercular evaluation, molecular docking and HSA binding studies.
    Pradeep Kumar CB; Prathibha BS; Prasad KNN; Raghu MS; Prashanth MK; Jayanna BK; Alharthi FA; Chandrasekhar S; Revanasiddappa HD; Yogesh Kumar K
    Bioorg Med Chem Lett; 2021 Mar; 36():127810. PubMed ID: 33482292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel and highly potential inhibitors of glycogen synthase kinase 3-beta (GSK-3β) through structure-based pharmacophore modeling, virtual computational screening, docking and in silico ADMET analysis.
    Benghanem S; Mesli F; Fatima Zohra HA; Nacereddine C; Hadjer C; Abdellatif M
    J Biomol Struct Dyn; 2024 Sep; 42(14):7091-7106. PubMed ID: 37498130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrids of thiazolidinone with 1,2,3-triazole derivatives: design, synthesis, biological evaluation,
    Bimoussa A; Fawzi M; Oubella A; Ejaz SA; Sajjad Bilal M; Labd Taha M; Auhmani A; Morjani H; Robert A; Riahi A; Ait Itto MY
    J Biomol Struct Dyn; 2023; 41(21):11987-11999. PubMed ID: 36617941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 1,2,4-triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studies.
    Turky A; Sherbiny FF; Bayoumi AH; Ahmed HEA; Abulkhair HS
    Arch Pharm (Weinheim); 2020 Dec; 353(12):e2000170. PubMed ID: 32893368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives.
    Duan M; Mahal A; Alkouri A; Wang C; Zhang Z; Ren J; Obaidullah AJ
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38998962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro anticancer evaluation of newly designed and characterized tri/tetra-substituted imidazole congeners- maternal embryonic leucine zipper kinase inhibitors: Molecular docking and MD simulation approaches.
    Mahapatra M; Mohapatra P; Pakeeraiah K; Bandaru RK; Ahmad I; Mal S; Dandela R; Sahoo SK; Patel H; Paidesetty SK
    Int J Biol Macromol; 2023 Sep; 249():126084. PubMed ID: 37532192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and cytotoxic activities of novel hybrid 2-phenyl-3-alkylbenzofuran and imidazole/triazole compounds.
    Chen W; Deng XY; Li Y; Yang LJ; Wan WC; Wang XQ; Zhang HB; Yang XD
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4297-302. PubMed ID: 23800685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, anticancer, antimicrobial activities and molecular docking studies of theophylline containing acetylenes and theophylline containing 1,2,3-triazoles with variant nucleoside derivatives.
    Ruddarraju RR; Murugulla AC; Kotla R; Chandra Babu Tirumalasetty M; Wudayagiri R; Donthabakthuni S; Maroju R; Baburao K; Parasa LS
    Eur J Med Chem; 2016 Nov; 123():379-396. PubMed ID: 27487568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship of dual inhibitors containing maleimide and imidazole motifs against glutaminyl cyclase and glycogen synthase kinase-3β.
    Wei D; Cai J; Qin F; Zhou Q; Xiong W; Xu C; Li C; Wu H
    Bioorg Med Chem Lett; 2024 Sep; 110():129851. PubMed ID: 38906336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
    Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis and Anticancer Screening of Novel Benzothiazole-Piperazine-1,2,3-Triazole Hybrids.
    Aouad MR; Soliman MA; Alharbi MO; Bardaweel SK; Sahu PK; Ali AA; Messali M; Rezki N; Al-Soud YA
    Molecules; 2018 Oct; 23(11):. PubMed ID: 30373247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis and Biological Evaluation of 7-Chloro-9
    Andreev S; Pantsar T; Ansideri F; Kudolo M; Forster M; Schollmeyer D; Laufer SA; Koch P
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31242571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Click chemistry based synthesis, cytotoxic activity and molecular docking of novel triazole-thienopyrimidine hybrid glycosides targeting EGFR.
    Khattab RR; Alshamari AK; Hassan AA; Elganzory HH; El-Sayed WA; Awad HM; Nossier ES; Hassan NA
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):504-516. PubMed ID: 33504239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.